Adherence
Social media promotion and celebrity endorsements of semaglutide (specifically Ozempic/Wegovy) for off-label weight loss directly drive global search interest and subsequent supply shortages, overriding regulatory approval timelines.
Search interest in weight loss drugs like semaglutide is currently driven more by social media trends and celebrity endorsements than by official medical approvals. If you are seeing a surge in interest or shortages, it is likely due to viral media content rather than a change in medical guidelines.
The shifts in search probability for each country have coincided less with the per-country approval dates of semaglutide, and more with the media reporting and social media discussion of semaglutide.
Why this rating
Large-scale infodemiological study using Google Trends Extended for Health across 27 countries with Granger causality analysis.
Source
Sweetening the deal: an infodemiological study of worldwide interest in semaglutide using Google Trends extended for health application programming interface
Jacques Raubenheimer et al. · BMC Global and Public Health · 2024
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →